Javascript must be enabled to continue!
Beyond AI Transparency: A Reproducibility-Centred Governance Framework for Adaptive Generative AI Across the Medical Research Lifecycle
View through CrossRef
Background: Generative artificial intelligence (GenAI) is rapidly transforming health informatics through applications in evidence synthesis, clinical decision support, digital biomarkers, and healthcare research. However, the adaptive nature of foundation models introduces reproducibility challenges that extend beyond the scope of conventional AI governance. This review examines reproducibility as a foundational requirement for trustworthy healthcare AI. Methods: A critical narrative review was conducted following the Scale for the Assessment of Narrative Review Articles (SANRA). Literature published between January 2018 and June 2026 was identified through PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore, Google Scholar, and citation tracking. Evidence was synthesised using an abductive interpretive approach to identify methodological gaps and develop a conceptual governance framework. Results: The review makes three principal contributions. First, it proposes a three-domain framework comprising computational, scientific, and clinical reproducibility. Second, it introduces the transparency–reproducibility gap, demonstrating why transparent reporting alone cannot ensure reproducibility as adaptive AI systems evolve. Third, it presents the Transparency–Observability–Assurance (TOA) Framework, a reproducibility-centred governance model integrating transparency, observability, and assurance throughout the AI lifecycle. Across multiple healthcare applications, reproducibility challenges were shown to affect scientific evidence generation, clinical decision-making, and digital measurement. Conclusions: Reproducibility should be recognised as a dynamic lifecycle property requiring continuous evaluation beyond initial validation. The proposed TOA Framework provides a conceptual foundation for reproducibility-centred governance of adaptive healthcare AI.
Title: Beyond AI Transparency: A Reproducibility-Centred Governance Framework for Adaptive Generative AI Across the Medical Research Lifecycle
Description:
Background: Generative artificial intelligence (GenAI) is rapidly transforming health informatics through applications in evidence synthesis, clinical decision support, digital biomarkers, and healthcare research.
However, the adaptive nature of foundation models introduces reproducibility challenges that extend beyond the scope of conventional AI governance.
This review examines reproducibility as a foundational requirement for trustworthy healthcare AI.
Methods: A critical narrative review was conducted following the Scale for the Assessment of Narrative Review Articles (SANRA).
Literature published between January 2018 and June 2026 was identified through PubMed/MEDLINE, Scopus, Web of Science, IEEE Xplore, Google Scholar, and citation tracking.
Evidence was synthesised using an abductive interpretive approach to identify methodological gaps and develop a conceptual governance framework.
Results: The review makes three principal contributions.
First, it proposes a three-domain framework comprising computational, scientific, and clinical reproducibility.
Second, it introduces the transparency–reproducibility gap, demonstrating why transparent reporting alone cannot ensure reproducibility as adaptive AI systems evolve.
Third, it presents the Transparency–Observability–Assurance (TOA) Framework, a reproducibility-centred governance model integrating transparency, observability, and assurance throughout the AI lifecycle.
Across multiple healthcare applications, reproducibility challenges were shown to affect scientific evidence generation, clinical decision-making, and digital measurement.
Conclusions: Reproducibility should be recognised as a dynamic lifecycle property requiring continuous evaluation beyond initial validation.
The proposed TOA Framework provides a conceptual foundation for reproducibility-centred governance of adaptive healthcare AI.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Non-Recommended Publishing Lists: Strategies for Detecting Deceitful Journals
Abstract
The rapid growth of open access publishing (OAP) has significantly improved the accessibility and dissemination of scientific knowledge. However, this expansion has also c...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Transparency, reproducibility, and replicability in human resource management research
Transparency, reproducibility, and replicability in human resource management research
PurposeWe address the importance of strategies for improving transparency, reproducibility, and replicability in human resource management research.Design/methodology/approachWe re...
Hubungan Kualitas Audit, Komite Audit, dan Dewan Pengawas Syariah terhadap Kinerja Bank Umum Syariah di Indonesia
Hubungan Kualitas Audit, Komite Audit, dan Dewan Pengawas Syariah terhadap Kinerja Bank Umum Syariah di Indonesia
ABSTRAK
Penelitian ini ditujukan untuk mengetahui hubungan kualitas audit, komite audit, dan Dewan Pengawas Syariah (DPS) terhadap kinerja Bank Umum Syariah di Indonesia pada tahun...
Towards the Synthesis of Product Knowledge Across the Lifecycle
Towards the Synthesis of Product Knowledge Across the Lifecycle
Product lifecycle management is an important aspect of today’s industry, as it serves to facilitate information exchange and management between most, if not all, stages of a produc...
Understanding reproducibility of bioinformatics workflows
Understanding reproducibility of bioinformatics workflows
Reproducibility is an essential factor in establishing the reliability of results reported in the scientific literature and ultimately in the knowledge that is generated. This know...

